Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Luo Han Guo Antitussive Capsules is a traditional Chinese medicine (TCM) formulation developed and manufactured by Jilin Fukang Pharmaceutical. The product is primarily indicated for the treatment of cough and respiratory symptoms, particularly those associated with lung heat and phlegm. The formulation's primary active component is derived from *Siraitia grosvenorii* (Luo Han Guo), which is traditionally recognized in Chinese medicine for its ability to clear heat, moisten the lungs, and act as an expectorant. It is administered orally and is currently approved and marketed in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Luo Han Guo Antitussive Capsules.